Customer Support: 800-526-4902
 
Home > Legal Library > Advanced Search > Search Results





Practice Area Resource Centers

We currently offer the following Practice Areas: Litigation; Intellectual Property; Real Estate; Corporate Law; Bankruptcy; Business Law; Insurance; Taxation and more...

 






Join Matindale-Hubbell Connected



Jones Day San Diego, CA Document Search Results (6)

 

Sort by:
Sponsored Results

HTMLSEC and CFTC Publish Proposed Identity Theft Red Flag Rules for Public Comment
Veronica K. McGregor, Mauricio F. Paez, Katherine S. Ritchey, Elaine Wallace; Jones Day;
Legal Alert/Article
March 28, 2012, previously published on March 2012
On February 28, 2012, the Securities and Exchange Commission ("SEC") and the Commodity Futures Trading Commission ("CFTC") issued proposed rules and guidelines, requiring broker-dealers, mutual funds, and other SEC- and CFTC-regulated entities to create programs to detect and...

 

HTML2011 California Labor and Employment Legislative Update
Aaron L. Agenbroad, Richard J. Bergstrom, George S. Howard, F. Curt Kirschner, Robert A. Naeve, Deborah Crandall Saxe, Steven M. Zadravecz; Jones Day;
Legal Alert/Article
November 7, 2011, previously published on November 2011
In early October, California Governor Jerry Brown signed a variety of important employment and labor-related statutes. Although Gov. Brown vetoed several additional anti-employer measures, this year marks a turning point for employers with workforces in California. We anticipate that the 2012...

 

HTMLPresident Obama Proposes Reducing the Exclusivity Period of Brand-Name Biological Products
Jonathan Berman, Laura A. Coruzzi, Anthony M. Insogna; Jones Day;
Legal Alert/Article
September 22, 2011, previously published on September 2011
President Obama, in his new budget plan, proposes reducing the exclusivity period for brand-name biologics from 12 years to seven. The President would also limit the ability of manufacturers to obtain additional periods of exclusivity.

 

HTMLCertain Post-Approval Activities to Support Submissions to the FDA Are Now Subject to Claims of Patent Infringement
Jonathan Berman, Anthony M. Insogna; Jones Day;
Legal Alert/Article
September 22, 2011, previously published on September 2011
On August 31, the Federal Circuit significantly restricted the scope of the "safe harbor" provision of 35 U.S.C. § 271(e)(1), which immunizes the use of patented inventions in connection with regulatory submissions to the Food and Drug Administration ("FDA"). Classen...

 

Adobe PDFThe 2011 Patent Reform Act
David B. Cochran, Thomas E. Friebel, Anthony M. Insogna, Ognjan V. Shentov, Peter G. Thurlow; Jones Day;
Legal Alert/Article
September 22, 2011, previously published on September 2011
The most significant changes to the U.S. patent law in more than 50 years have finally come to pass. The practice of U.S. patent law will never be the same. It took more than six years of Congressional debate for the U.S. Senate to pass the House version of the Leahy-Smith America Invents Act...

 

HTMLTherasense v. Becton, Dickinson: The Federal Circuit Heightens the Standard for Proving Inequitable Conduct in Patent Litigation
Julie M. Baher, Gregory A. Castanias, Jonathan A. Muenkel, Jose L. Patiño; Jones Day;
Legal Alert/Article
June 15, 2011, previously published on June 2011
On May 25, 2011, the Federal Circuit issued its much-anticipated en banc opinion in Therasense, Inc. v. Becton, Dickinson & Co. In that opinion, the Federal Circuit "tighten[ed]" the standards for proving inequitable conduct in patent litigation, requiring heightened showings of both...